Cryotherapy for liver metastases: A new approach
โ Scribed by R. M. Charnley; J. Doran; Mr. D. L. Morris
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 310 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
A new system designed for cryosurgery of liver metastases is described. The cryoprobe, which utilizes circulating liquid nitrogen and produces a spherical iceball around each metastasis, is controlled by operative ultrasound. There was nor mortality and all patients left hospital within 10 days. Cryotherapy produced an area of destruction within the liver substance which decreased in size by 6 weeks as shown on serial computed tomographic scanning.
๐ SIMILAR VOLUMES
While the prognosis for patients with untreated liver metastases from neuroendocrine primaries is rather good, they often suffer disabling symptoms due to syndromes of hormonal excess. Thirteen patients with metastatic neuroendocrine tumours were treated by hepatic cryotherapy; seven patients were s
## Background and objectives: Most patients with colorectal liver metastases are not eligible for resection because they have multiple lesions or because of anatomical constraints. we report the use of cryotherapy to destroy residual metastases following liver resection in patients with disease too
Abstract A 6 12 year experience in the management of hepatic colorectal metastases in a specialist unit is reviewed. During the period studied, 48 patients were referred of whom only 24 actually came to resection. There were two in-hospital deaths, at 20 and 60 days, and six patients had non-fatal c
## Abstract ## BACKGROUND The number of hepatic metastases for which resection or ablation is appropriate remains controversial. ## METHODS A retrospective analysis was performed of prospectively collected data from patients with liver metastases from colorectal carcinoma who underwent hepatic c
## Background and objectives: After curative resection of hepatic colorectal metastases, 10-20% of patients experience a resectable hepatic recurrence. we wanted to assess the expected risk-to-benefit ratio in comparison to first hepatectomy and to determine the prognostic factors associated with s